Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 3,235 | 0.0% | 4,191 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,786 | 0.0% | 3,176 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 2,013 | 0.0% | 3,834 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 2,622 | 0.0% | 4,133 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 2,733 | 0.0% | 3,836 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 4,172 | 0.0% | 3,969 | 9/30/2024 |
| 2024 Q2 | 8/16/2024 | 4,016 | 0.0% | 3,821 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 3,162 | 0.0% | 3,285 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 3,298 | 0.0% | 3,755 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 3,019 | 0.0% | 3,669 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 2,601 | 0.0% | 3,620 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,979 | 0.0% | 3,626 | 3/31/2023 |
| 2022 Q4 | 2/21/2023 | 2,790 | 0.0% | 3,867 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 2,535 | 0.0% | 3,679 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 2,294 | 0.0% | 3,880 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 2,223 | 0.0% | 3,182 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 2,315 | 0.0% | 3,665 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 2,318 | 0.0% | 3,832 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 1,767 | 0.0% | 3,163 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 1,363 | 0.0% | 2,880 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,219 | 0.0% | 2,520 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 1,422 | 0.0% | 2,539 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 1,470 | 0.0% | 2,357 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 1,051 | 0.0% | 2,152 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 1,064 | 0.0% | 2,834 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 1,023 | 0.0% | 3,622 | 6/30/2014 |
| 2014 Q1 | 5/15/2014 | 981 | 0.0% | 3,266 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 857 | 0.0% | 3,115 | 12/31/2013 |